Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Public ClinicalTrials.gov record NCT00045864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.
Study identification
- NCT ID
- NCT00045864
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Feb 6, 2006
United States locations
- U.S. sites
- 33
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ACRC/Arizona Clinical Research Center, Inc. | Tucson | Arizona | 85712 | — |
| Hoag Cancer Center | Newport Beach | California | 92658 | — |
| UC Davis Cancer Center | Sacramento | California | 95817 | — |
| John Wayne Cancer Institute | Santa Monica | California | 90404 | — |
| Stanford University Medical Center | Stanford | California | 94305-5151 | — |
| California Cancer Medical Center | West Covina | California | 91790 | — |
| Georgetown University Medical Center, Lombardi Cancer Center | Washington D.C. | District of Columbia | 20007 | — |
| Washington Cancer Institute | Washington D.C. | District of Columbia | 20010 | — |
| Division of Hematology/Oncology, University of Miami School of Medicine | Miami | Florida | 333136 | — |
| Northwestern University, Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Rush Cancer Institute | Chicago | Illinois | 60612 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Cancer Care Center | Bloomington | Indiana | 47403 | — |
| Consultants in Blood Disorders and Cancer | Louisville | Kentucky | 40207 | — |
| Louisiana Health Sciences Center, Department of Medicine, Hematology/Oncology | Shreveport | Louisiana | 71130 | — |
| Kansas City Oncology and Hematology Group | Kansas City | Missouri | 64111 | — |
| Arch Medical Group, LLC | St Louis | Missouri | 63141 | — |
| Dartmouth-Hitchcock-Medical Center | Lebanon | New Hampshire | 03756 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | — |
| Our Lady of Mercy Medical Center, Comprehensive Cancer Center | The Bronx | New York | 10466 | — |
| East Carolina University School of Medicine/ Division of Hematology/Oncology | Greenville | North Carolina | 27858 | — |
| Roger Maris Health System | Fargo | North Dakota | 58122 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Oncology Hematology Care Inc. | Cincinnati | Ohio | 45242 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Hematology /Oncology Consultants Inc. | Columbus | Ohio | 43235 | — |
| Oregon Heath and Science University | Portland | Oregon | 97201 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29615 | — |
| Germantown Cancer Center | Germantown | Tennessee | 38138 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Cancer Specialists of South Texas, P.A. | Corpus Christi | Texas | 78412 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00045864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2006 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00045864 live on ClinicalTrials.gov.